News :: Fresh Tracks Therapeutics, Inc. (FRTX)

Contact Us

Mar 18, 2020 4:01pm EDT

Brickell Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Mar 09, 2020 4:05pm EDT

Brickell Biotech to Report Fourth Quarter and Full Year 2019 Financial Results on March 18, 2020

Mar 04, 2020 6:30am EST

Brickell Biotech Announces Late-Breaking Oral Presentation at 2020 American Academy of Dermatology Annual Meeting by its Asian Partner, Kaken Pharmaceutical, for Sofpironium Bromide

Feb 20, 2020 6:30am EST

Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Primary Axillary Hyperhidrosis in the Journal of the American Academy of Dermatology

Feb 18, 2020 6:30am EST

Brickell Biotech Announces Settlement of Dispute with Bodor Labs and Entry into Equity Funding Agreements

Jan 10, 2020 4:05pm EST

Brickell Bio’s Development Partner, Kaken Pharmaceutical, Submits New Drug Application for Sofpironium Bromide in Japan for Primary Axillary Hyperhidrosis

Nov 13, 2019 4:05pm EST

Brickell Bio Announces Third Quarter 2019 Financial Results and Provides Corporate Update

Oct 30, 2019 4:42pm EDT

Brickell Biotech Provides Update on Bodor Labs Complaint and Funding Agreement with NovaQuest

Sep 03, 2019 6:00am EDT

Brickell Biotech Completes Merger with Vical

Jun 03, 2019 3:00am EDT

Vical and Brickell Announce Merger Agreement